SUBSCRIBE
SUBSCRIBE

Patient recruitment

PRESS RELEASES
Press Releases
Latigo Biotherapeutics Doses First Participant in Phase 1 Clinical Trial of LTG-305 for Non-Opioid Treatment of Pain
October 17, 2024
 · 
3 min read
Press Releases
AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy Study
October 16, 2024
 · 
2 min read
Press Releases
Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD
October 15, 2024
 · 
11 min read
Press Releases
MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease
October 15, 2024
 · 
5 min read
Press Releases
Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke
October 15, 2024
 · 
4 min read
Press Releases
Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
October 8, 2024
 · 
7 min read
Press Releases
Health Canada Approves Label Expansion for Telix’s Illuccix® to Include Patient Selection for PSMA-Targeted Therapy
October 7, 2024
 · 
7 min read
Press Releases
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3
September 30, 2024
 · 
6 min read
Press Releases
ImPact Biotech Announces 50% Enrollment in Phase 3 ENLIGHTED Clinical Trial of Padeliporfin VTP in Low Grade Upper Tract Urothelial Cancer
September 30, 2024
 · 
2 min read
Press Releases
Elixirgen Therapeutics Receives Rare Pediatric Disease Designation for EXG-34217 in Dyskeratosis Congenita and Related Telomere Biology Disorders
September 26, 2024
 · 
2 min read
Press Releases
Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
September 11, 2024
 · 
5 min read
Press Releases
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
August 22, 2024
 · 
5 min read
Press Releases
Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
August 15, 2024
 · 
4 min read
Press Releases
Artax Biopharma completes patient recruitment in Phase 2a trial with first-in-class Nck modulator AX-158
August 14, 2024
 · 
3 min read
Press Releases
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
July 31, 2024
 · 
14 min read
Press Releases
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
July 29, 2024
 · 
5 min read
Press Releases
Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure
July 25, 2024
 · 
7 min read
Press Releases
Nicox Announces Recruitment of Last Patient in U.S. in Denali Phase 3 Trial of NCX 470
July 25, 2024
 · 
4 min read
Press Releases
Breakthrough Technology Study for Patients Suffering From Life-threatening Bloodstream Infections Proceeds Into Next Phase With First Patient Enrollment
July 10, 2024
 · 
5 min read
Drug Development
Spectral Medical Provides June 2024 Tigris Trial Update
July 3, 2024
 · 
3 min read
Load More